- Activity pressure is positive on the latest completed week.
AIAI
TOR
Week ended 24 Jul 2026
Weekly Investor Report
NetraMark Holdings Inc. · Healthcare · Health Information Services
Latest close
0.78 CAD
-2.5%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -16.4% below the Trend Line and sits at 15.7% of its 52-week range. The latest completed week returned -2.5%, after a 25.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
31
out of 100
Latest Close
0.78 CAD
24 Jul 2026
1W Return
-2.5%
latest completed week
4W Return
25.8%
short-term follow-through
12W Return
-11.4%
quarterly tape
Trend Breadth
19.2%
10 of 52 weeks active
Volume Ratio
0.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 39.79% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.5%
Latest completed week; four-week move 25.8%.
Indicator stack
11/64
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 39.79%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -16.4% below the Trend Line and sits at 15.7% of its 52-week range. The latest completed week returned -2.5%, after a 25.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2312-week average 0.22
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.23Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 25.8% over four weeks, -11.4% over 12 weeks, and -46.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year10
Trend breadth19.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.17Latest activity-pressure read.
Pressure change133.3%Four-week change in activity pressure.
Leadership-36.97Latest relative-leadership reading.
RS change29.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 70%
Model confidence 67%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength44/100Blend of value, momentum, and quality. Underlying universe rank 57; rank 1 is best.
Value47/100Relative valuation strength. Underlying universe rank 54; rank 1 is best.
Quality48/100Profitability and accounting quality. Underlying universe rank 53; rank 1 is best.
Momentum48/100Medium-term price momentum. Underlying universe rank 53; rank 1 is best.
Growth50/100Revenue and earnings growth. Underlying universe rank 51; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 417.7x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -7.1% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- - Gross profit retained from each unit of revenue.
- Operating margin
- -3638.7% Operating profit retained from revenue.
- Free-cash-flow margin
- -2800.9% Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -5.2% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -4.1% Net share repurchases relative to market value.
- Shareholder yield
- -4.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.6x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-56.7%Distance below the 52-week high.
13-week volatility13.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher8 of 2616 weeks finished lower.
Best week+29.0%Week of 3 Jul.
Worst week-21.5%Week of 26 Jun.
Latest week-2.5%Week of 24 Jul.
Shape of recent returns
Strong gains6
Modest gains2
Flat weeks2
Modest losses4
Sharp losses12
Recent vol13.8%13-week weekly-return volatility.
Base vol9.8%52-week weekly-return volatility.
Up/down split17/32Count of positive and negative weeks in the 52-week window.
Average skew10.6% / -6.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCA Healthcare
4-week rank2 / 47
Group average-0.8%
Trend breadth38.3%
Trend38.3%active weekly trend signals
MD48.9%positive activity pressure
RS27.7%positive relative leadership
Four-week leaders
IndustryCA Health Information Services
4-week rank1 / 4
Group average2.4%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD75.0%positive activity pressure
RS25.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape22/100
Trend, activity pressure, participation, and risk combine to a 22/100 tape read.
Indicator analysis21/100Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 0/12.
Activity pressure 0.23; No reversal markers Next-Week ExpectancyNegative 39.79%Next-week expectancy is negative with a 39.79% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors46/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 83; Small Cap Core rank 54 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 0.78 CAD | -2.5% | 0.93 CAD | 0.79 CAD | 0.17 | -36.97 | 58.3K | Off |
| 17 Jul 2026 | 0.80 CAD | -13.0% | 0.94 CAD | 0.79 CAD | -0.01 | -36.24 | 211.6K | Off |
| 10 Jul 2026 | 0.92 CAD | 15.0% | 0.96 CAD | 0.78 CAD | -0.23 | -27.94 | 83.7K | Off |
| 3 Jul 2026 | 0.80 CAD | 29.0% | 0.97 CAD | 0.78 CAD | -0.42 | -37.89 | 334.9K | Off |
| 26 Jun 2026 | 0.62 CAD | -21.5% | 0.98 CAD | 0.78 CAD | -0.51 | -52.18 | 245.3K | Off |
| 19 Jun 2026 | 0.79 CAD | -2.5% | 0.99 CAD | 0.77 CAD | -0.13 | -40.09 | 25.5K | Off |
| 12 Jun 2026 | 0.81 CAD | -4.7% | 1.00 CAD | 0.77 CAD | 0.12 | -39.45 | 4.3K | Off |
| 5 Jun 2026 | 0.85 CAD | -4.5% | 1.01 CAD | 0.77 CAD | 0.15 | -36.39 | 28.5K | Off |
| 29 May 2026 | 0.89 CAD | -6.3% | 1.02 CAD | 0.76 CAD | 0.48 | -34.98 | 604.4K | Off |
| 22 May 2026 | 0.95 CAD | 6.7% | 1.04 CAD | 0.76 CAD | 0.07 | -30.87 | 138.7K | Off |
| 15 May 2026 | 0.89 CAD | -15.2% | 1.05 CAD | 0.76 CAD | -0.20 | -34.79 | 112.5K | Off |
| 8 May 2026 | 1.05 CAD | 19.3% | 1.06 CAD | 0.75 CAD | -0.41 | -24.66 | 478.1K | Off |
| 1 May 2026 | 0.88 CAD | -4.3% | 1.07 CAD | 0.75 CAD | -1.05 | -37.10 | 169.7K | Off |
| 24 Apr 2026 | 0.92 CAD | 0.0% | 1.08 CAD | 0.75 CAD | -1.10 | -35.17 | 214.5K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.